POSSIBILITIES FOR THERAPY OF A COMORBIDITY OF UTERINE MYOMA AND BENIGN BREAST DYSPLASIAS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To improve the reproductive health of women with ben ign breast dysplasia (BBD) and uterine myoma, by elaborating a differentiated approach to preventing and treating comorbid diseases. Subject and methods. The investigation included 175 women with concomitant genital diseases and BBD who were treated at the Gynecology Unit, City Clinical Hospital Twelve. The results of their examination and differentiated treatment for comorbid diseases of the uterus and breast were analyzed. Results. The altered ratio of steroid hormone levels as absolute or relative hyperestrogenemia underlies the pathogenesis of BBD in women with uterine myoma. The elaborated differentiated approach allows quality of life to be improved by 43.4%. Conclusion. The findings strongly suggest that the women of this category must form a special follow-up gynecological group and their treatment must be a preventive measure against the progression and recurrence of BBD.

Full Text

Restricted Access

About the authors

V. E RADZINSKY

Peoples' Friendship University of Russia

Email: E-maihradzmsky@maM.ru
Department of Obstetrics and Gynecology with Course of Perinatology

I. M ORDIYANTS

Peoples' Friendship University of Russia

Department of Obstetrics and Gynecology with Course of Perinatology

M. N MASLENNIKOVA

Peoples' Friendship University of Russia

Department of Obstetrics and Gynecology with Course of Perinatology

E. A PAVLOVA

Peoples' Friendship University of Russia

Department of Obstetrics and Gynecology with Course of Perinatology

V. V KARDANOVA

Peoples' Friendship University of Russia

Department of Obstetrics and Gynecology with Course of Perinatology

References

  1. Кулаков В.И., Манухин И.Б., Савельева Г.М., ред. Гинекология: Национальное руководство. М.: ГЭОТАРМедиа; 2007. 1072с.
  2. Сутурина Л.В., Попова Л.Н. Влияние бромкриптина и циклодинона на клинические симптомы и уровень пролактина с гиперпролактинемией репродуктивного возраста. Вопросы гинекологии, акушерства и перинатологии. 2010; 9(2): 41-3.
  3. Хасханова Л.Х. Прогнозирование, ранняя диагностика и лечение нераковых заболеваний молочных желез после хирургического лечения гинекологических заболеваний: Автореф. дис.. д-ра мед. наук. М.; 2003. 47с.
  4. Коновалова В.Н. Дискуссионные вопросы тактики ведения женщин с доброкачественными заболеваниями молочных желез. Эффективная фармакотерапия в акушерстве и гинекологии. 2009; 6: 6-12.
  5. Прилепская В.Н, Тагиева Т.Т. Фиброзно-кистозная болезнь молочных желез: возможности негормональной терапии. Медлайн-Экспресс. 2008; 5: 10-7.
  6. Филиппов О.С. Доброкачественные заболевания молочных желез. М.: МЕДПресс-информ; 2008. 112с.
  7. Радзинский В.Е. Лекарственные растения в акушерстве и гинекологии. 8-е изд. М.: ЭКСМО; 2008. 317с.
  8. Рожкова Н.И., Меских Е.В. Мастодинон: возможности применения при различных формах мастопатии. Опухоли женской репродуктивной системы. 2008; 4: 46-7.
  9. Радзинский В.Е. Молочные железы и гинекологические болезни. М.: Status Praesens; 2010. 304с.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Bionika Media